申请人:BASF Aktiengesellschaft
公开号:US06352981B1
公开(公告)日:2002-03-05
Aza- and diazacyclohexane and -cyclooctane compounds of the following formula:
Ar1—A—B—Ar2 (I)
where Ar1, A, B and Ar2 have the meanings stated in the description have a high affinity for the dopamine D3 receptor and can therefore be used to treat disorders which respond to dopamine D3 ligands.
以下化合物的化学式为:Ar1—A—B—Ar2(I),其中Ar1、A、B和Ar2的含义如描述中所述,具有高亲和力,可用于治疗对多巴胺D3受体有响应的疾病。